T1	Participants 62 115	patients with implantable cardioverter defibrillators
T2	Participants 260 320	patients with implantable cardioverter defibrillators (ICDs)
T3	Participants 710 722	172 patients
T4	Participants 867 973	majority of patients had a history of documented remote myocardial infarction and congestive heart failure
